Gene expression profiling provides insights into pathways of oxaliplatin-related sinusoidal obstruction syndrome in humans

Molecular Cancer Therapeutics

Volumn 10, Issue 4, 2011, Pages 687-696

  Rubbia Brandt, Laura ^a   Tauzin, Sébastien ^a   Brezault, Catherine ^c   Delucinge Vivier, Céline ^b   Descombes, Patrick ^b   Dousset, Bertand ^c   Majno, Pietro E ^a   Mentha, Gilles ^a   Terris, Benoit ^c  

^a GENEVA UNIVERSITY HOSPITALS   (Switzerland)

^b UNIVERSITY OF GENEVA   (Switzerland)

^c université Paris Cité   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; BEVACIZUMAB; CYTOKINE; FLUOROURACIL; FOLINIC ACID; GELATINASE A; INTERLEUKIN 6; MACROPHAGE INFLAMMATORY PROTEIN 3ALPHA; MESSENGER RNA; OXALIPLATIN; PLATELET DERIVED GROWTH FACTOR A; TISSUE INHIBITOR OF METALLOPROTEINASE 1; VASCULOTROPIN C; VON WILLEBRAND FACTOR;

ACUTE PHASE RESPONSE; ARTICLE; BLOOD CLOTTING; CLINICAL ASSESSMENT; CLINICAL OBSERVATION; CLUSTER ANALYSIS; CONTROLLED STUDY; DNA MICROARRAY; DOWN REGULATION; EMERGENCY TREATMENT; GENE CONTROL; GENE EXPRESSION; GENE EXPRESSION PROFILING; HUMAN; HUMAN TISSUE; LIVER FIBROSIS; LIVER METASTASIS; LIVER TOXICITY; LIVER VEIN OBSTRUCTION; MORBIDITY; MORTALITY; MULTIPLE CYCLE TREATMENT; OXIDATIVE STRESS; PATHOGENESIS; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SINUDOIDAL OBSTRUCTION SYNDROME; SINUSOIDAL OBSTRUCTION SYNDROME; STELLATE CELL; STEM CELL; UPREGULATION; VEIN OCCLUSION;

CHEMOKINE CCL20; CLUSTER ANALYSIS; GENE EXPRESSION PROFILING; HEPATIC VENO-OCCLUSIVE DISEASE; HUMANS; HYPOXIA-INDUCIBLE FACTOR 1, ALPHA SUBUNIT; IMMUNOHISTOCHEMISTRY; LIVER; MICROARRAY ANALYSIS; ORGANOPLATINUM COMPOUNDS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; SIGNAL TRANSDUCTION; VASCULAR ENDOTHELIAL GROWTH FACTOR C;

EID: 79955757114     PISSN: 15357163     EISSN: 15388514     Source Type: Journal    
DOI: 10.1158/1535-7163.MCT-10-1072     Document Type: Article

References (50)

1. Rubbia-Brandt L, Audard V, Sartoretti P, Roth AD, Brezault C, Le Charpentier M, et al. Severe hepatic sinusoidal obstruction associated with oxaliplatin-based chemotherapy in patients with metastatic colorectal cancer. Ann Oncol 2004;15:460-66. (Pubitemid 38444550)
2. Rubbia-Brandt L, Lauwers GY, Wuang H, Majno PE, Tanabe K, Zhu A, et al. Sinusoidal obstruction syndrome and nodular regenerative hyperplasia are frequent oxaliplatin associated liver lesions and partially prevented by bevacizumab in patients with hepatic colorectal metastasis. Histopathology 2010;56:430-9.
3. Chun YS, Laurent A, Maru D, Vauthey JN. Management of chemotherapy-associated hepatotoxicity in colorectal liver metastases. Lancet Oncol 2009;10:278-86.
4. Aloia T, Sebagh M, Plasse M, Lévi F, Giacchetti S, Azoulay D, et al. Liver histology and surgical outcomes after preoperative chemotherapy with fluorouracil plus oxaliplatin in colorectal cancer liver metastases. J Clin Oncol 2006:24:4983-90. (Pubitemid 46631400)
5. Hubert C, Sempoux C, Horsmans Y, Rahier J, Humblet Y, Machiels JP, et al. Nodular regenerative hyperplasia: a deleterious consequence of chemotherapy for colorectal liver metastases? Liver Int 2007;1478:938-42.
6. Arotcarena R, Calès V, Berthelemy Ph, Parent Y, Malet M, Etcharry F, et al. Severe sinusoïdal lesions: a serious and overlooked complication of oxaliplatin-containing chemotherapy? Gastroenlerol Clin Biol 2006;30:1313-16.
7. Nakano H, Oussoultzoglou E, Rosso E, Casnedi S, Chenard-Neu MP, Dufour P, et al. Sinusoidal injury increases morbidity after major hepatectomy in patients with colorectal liver metastases receiving preoperative chemotherapy.Ann Surg 2008;247:118-24.
8. Vauthey JN, Pawlik TM, Ribero D, Wu TT, Zorzi D, Hoff PM, et al. Chemotherapy regimen predicts steatohepatitis and an increase in 90-day mortality after surgery for hepatic colorectal metastases. J Clin Oncol 2006;24:2065-72. (Pubitemid 46622116)
9. Kandutsch S, Klinger M, Hacker S, Wrba F, Gruenberger B, Gruenberger T. Patterns of hepatotoxicity after chemotherapy for colorectal cancer liver metastases. Eur J Surg Oncol 2008;34:1231-6.
10. Tisman G, MacDonald D, Shindell N. Oxaliplatin toxicity masquerading as recurrent colon cancer. J Clin Oncol 2004;22:3202-4.
11. Karoui M, Penna C, Amin-Hashem M, Mitry E, Benoist S, Franc B, et al. Influence of preoperative chemotherapy on the risk of major hepatectomy for colorectal liver metastases. Ann Surg 2006;243:1-7. (Pubitemid 43054046)
12. Slade JH, Alattar ML, Fogelman DR, Overman MJ, Agarwal A, Maru DM, et al. Portal hypertension associated with oxaliplatin administration: clinical manifestations of hepatic sinusoidal injury. Clin Colorectal Cancer 2009 Oct;8:225-30.
13. Brouquet A, Benoist S, Julie C, Penna C, Beauchet A, Rougier P, et al. Risk factors for chemotherapy-associated liver injuries: a multivariate analysis of a group of 146 patients with colorectal metastases. Surgery 2009;145:362-71.
14. Bilchik AJ, Poston G, Curley SA, Strasberg S, Saltz L, Adam R, et al. Neoadjuvant chemotherapy for metastatic colon cancer: a cautionary note. J Clin Oncol 2005;23:9073-78.
15. Deleve LD. Hepatic microvasculature in liver injury. Semin Liver Dis 2007;27:390-400.
16. DeLeve LD, Valla D,, Garcia-Tsao G. Vascular Disorders of the Liver. Hepatology 2009;49:1729-64.
17. Rubbia-Brandt L. Sinusoidal obstruction syndrome. Clin Liver Dis 2010;14:651-68.
18. DeLeve LD, McCuskey RS, Wang X, Hu L, McCuskey MK, Epstein RB, et al. Characterization of a reproducible rat model of hepatic venoocclusive disease. Hepatology 1999;29:1779-91. (Pubitemid 29247052)
19. DeLeve LD, Ito I, Bethea NW, McCuskey MK, Wang X, McCuskey RS. Embolization by sinusoidal lining cell obstructs the microcirculation in rat sinusoidal obstruction syndrome. Am J Physiol Gastrointest Liver Physiol 2003;284:1045-1052.
20. Schiffer E, Frossard JL, Rubbia-Brandt L, Mentha G, Pastor C. Hepatic regeneration is decreased in a rat model of sinusoidal obstruction syndrome. J Surg Oncol 2009;99:439-46.
21. Bolstad BM, Irizarry RA, Astrand M, Speed TP. A comparison of normalization methods for high density oligonucleotide array data based on bias and variance. Bioinformatics 2003;19:185-193. (Pubitemid 36181903)
22. Hochberg Y, Benjamini Y. More powerful procedures for multiple significance testing. Stat Med 1990;9:811-818 (Pubitemid 20343989)
23. Gruaz L, Delucinge-Vivier C, Descombes P. Blockade of T cell contact-activation of human monocytes by high-density lipoproteins reveals a new pattern of cytokine and inflammatory genes. PLoS One 2010;25:9418-9423.
24. Copple BL, Ganey PE, Roth RA. Liver inflammation during monocrotaline hepatotoxicity. Toxicology 2003:28:190:155-69. (Pubitemid 36966703)
25. Gao B. Cytokines, STATs, and liver disease. Cell Mol Immunol 2005;2:92-100.
26. Wang M, Zhang W, Crisostomo P, Markel T, Meldrum KK, Fu XY, et al. Endothelial STAT3 plays a critical role in generalized myocardial proinflammatory and proapoptotic signaling. Am J Physiol Heart Circ Physiol 2007;293:2101-8.
27. Schutyser E, Struyf S, Van Damme J. The CC chemokine CCL20 and its receptor CCR6. Cytokine Growth Factor Rev 2003;14:409-26. (Pubitemid 37099454)
28. Ghadjar P, Rubie C, Aebersold DM, Keilholz U. The chemokine CCL20 and its receptor CCR6 in human malignancy with focus on colorectal cancer. Int J Cancer 2009;125:741-5.
29. Ghadjar P, Coupland SE, Na IK, Noutsias M, Letsch A, Stroux A, et al. Chemokine receptor CCR6 expression level and liver metastases in colorectal cancer. J Clin Oncol 2006;24:1910-6 (Pubitemid 46646227)
30. Laurance S, Pellay FX, Dossou-Yovo OP, Verger E, Krishnamoorthy R, Lapoumeroulie C, et al. Hydroxycarbamide stimulates the production of proinflammatory cytokines by endothelial cells: relevance to sickle cell disease. Pharmacogenet Genomics 2010;20:257-68.
31. Rebouissou S, Amessou M, Couchy G, Poussin K, Imbeaud S, Pilati C, et al. Frequent in-frame somatic deletions activate gp130 in inflammatory hepatocellular tumours. Nature 2009;457:200-4.
32. Bosco MC, Puppo M, Santangelo C, Anfosso L, Pfeffer U, Fardin P, et al. Hypoxia modifies the transcriptome of primary human monocytes: modulation of novel immune-related genes and identification of CC-chemokine ligand 20 as a new hypoxia-inducible gene. J Immunol 2006;177:1941-55. (Pubitemid 44092535)
33. Battaglia F, Delfino S, Merello E, Puppo M, Piva R, Varesio L, et al. Hypoxia transcriptionally induces macrophage-inflammatory protein-3alpha/CCL-20 in primary human mononuclear phagocytes through nuclear factor (NF)-kappaB. J Leukoc Biol 2008;83:648-62. (Pubitemid 351966875)
34. Copple BL, Banes A, Ganey PE, Roth RA. Endothelial cell injury and fibrin deposition in rat liver after monocrotaline exposure. Toxicol Sci 2002;65:309-18. (Pubitemid 34121123)
35. Lesurtel M, Graf R, Aleil B, Walther DJ, Tian Y, Jochum W, et al. Platelet-derived serotonin mediates liver regeneration. Science 2006;312:104-107.
36. Brooks SE, Miller CG, McKenzie K, Audretsch JJ, Bras G. Acute venoocclusive diseases of the liver. Fine structure in Jamaican children. Arch Pathol 1970;89:507-20.
37. Shulman HM, Gown AM, Nugent DJ. Hepatic veno-occlusive disease after bone marrow transplantation. Immunohistochemical identification of the material within occluded central venules. Am J Pathol 1987;127:549-58. (Pubitemid 17089816)
38. Soubrane O, Brouquet A, Zalinski S, Terris B, Brezault C, Mallet V, et al. Predicting high grade lesions of sinusoidal obstruction syndrome related to oxaliplatin-based chemotherapy for colorectal liver metastases correlation with post-hepatectomy outcome. Ann Surg 2010;251:454-60.
39. DeLeve LD, Wang X, Kuhlenkamp JF, Kaplowitz N. Toxicity of azathioprine and monocrotaline in murine sinusoidal endothelial cells and hepatocytes: the role of glutathione and relevance to hepatic venooclusive disease. Hepatology 1996;23:589-599. (Pubitemid 26087175)
40. Shulman HM, Fisher LB, Schoch HG, Henne KW, McDonald GB. Venoocclusive disease of the liver after marrow transplantation: histological correlates of clinical signs and symptoms. Hepatology 1994;19:117-1180.
41. Jiao J, Friedman SL, Aloman C. Hepatic fibrosis. Curr Opin Gastroenterol 2009;25:223-9.
42. Deleve LD, Wang X, Tsai J, Kanel G, Strasberg S, Tokes ZA. Sinusoidal obstruction syndrome (veno-occlusive disease) in the rat is prevented by matrix metalloproteinase inhibition. Gastroenterology 2003;125:882-90. (Pubitemid 37070704)
43. Zeng HH, Lu JF, Wang K. The effect of cisplatin and transplatin on the conformation and association of F-actin. Cell Biol Int 1995;19:491-97.
44. DeLeve LD, Wang X, Kanel GC, Ito Y, Bethea NW, McCuskey MK, et al. Decreased hepatic nitric oxide production contributes to the development of rat sinusoidal obstruction syndrome. Hepatology 2003;38:900-8. (Pubitemid 37221673)
45. Iguchi A, Kobayashi R, Yoshida M, Kobayashi K, Matsuo K, Kitajima I, et al. Vascular endothelial growth factor (VEGF) is one of the cytokines causative and predictive of hepatic veno-occlusive disease (VOD) in stem cell transplantation. Bone Marrow Transplant 2001;27:1173-80. (Pubitemid 32600290)
46. Vollmar B, Menger MD. The hepatic microcirculation: mechanistic contributions and therapeutic targets in liver injury and repair. Physiol Rev 2009:89:1269-1339.
47. DeLeve LD, Wang X, Hu L, McCuskey MK, McCuskey RS. Rat liver sinusoidal endothelial cell phenotype is maintained by paracrine and autocrine regulation. Rat liver sinusoidal endothelial cell phenotype is maintained by paracrine and autocrine regulation. Am J Physiol Gastrointest Liver Physiol 2004;287:G757-63.
48. Deleve LD, Wang X, Guo Y. Sinusoidal endothelial cells prevent rat stellate cell activation and promote reversion to quiescence. Hepatology 2008;48:920-30.
49. Ribero D, Wang H, Donadon M, Zorzi D, Thomas M, Eng C, et al. Bevacizumab improves pathologic response and protects against hepatic injury in patients treated with oxaliplatin-based chemotherapy for colorectal liver metastases. Cancer 2007;110:2761-7. (Pubitemid 350250347)
50. Klinger M, Eipeldauer S, Hacker S, Herberger B, Tamandl D, Dorfmeister M, et al. Bevacizumab protects against sinusoidal obstruction syndrome and does not increase response rate in neoadjuvant XELOX/FOLFOX therapy of colorectal cancer liver metastases. Eur J Surg Oncol 2009;35:515-20.